Both Retatrutide and Semaglutide are modern medications designed for addressing type 2 diabetes and promoting weight reduction . However, they function through distinct pathways. Wegovy is a GLP-1 receptor site agonist , while Retatrutide acts as a dual GIP and GLP-1 agonist , potentially offering a more significant impact on both glucose control a